Published Literature

Phase 3 Study of Reparixin in COVID-19 Pneumonia

Phase 2 Study of Reparixin in COVID-19 Pneumonia

Meta-analysis of Reparixin in Critically Ill and Transplant Patients

Meta-analysis of Reparixin in Patients at High Risk for Mortality

Reduction of NETosis by Targeting CXCR1/2 in Experimental Human and Murine Sepsis

Therapeutic inhibition of CXCR2 by Reparixin in Acute Lung Injury Mice

The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for Acute Respiratory Distress Syndrome

Chemokine Receptors CXCR1 and CXCR2 and their Role in Acute Respiratory Distress Syndrome

Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and Immunothrombosis

 

Clinical Trial Resources*

RESPIRATIO Clinical Trial Brochure- English RESPIRATIO Clinical Trial Brochure- Spanish RESPIRATIO Clinical Trial Poster- English RESPIRATIO Clinical Trial Poster- Spanish RESPIRATIO Clinical Trial Pocket Card- English RESPIRATIO Clinical Trial Pocket Card- Spanish

*These resources are intended for healthcare professionals only. Please contact the study team for other languages and for patient facing materials at your site.